Only a handful of articles for Kratom were available and included only small sample sizes. There were many Buprenorphine articles to choose from, because Buprenorphine is approved by the FDA. Also, the articles had large sample sizes which allowed the data to be generalized to all opioid dependent patients. Most research attached to Kratom is of self medicating Kratom users, most of which mix other drugs with Kratom and become ill. In some of the cases the benefits of Kratom include reduced opioid withdrawal symptoms and mild withdrawal symptoms when Kratom is ceased. Extended treatment of Buprenorphine, with counseling or a support system, is associated with better success. This could be due to the fact that patients are more compliant to take the prescribed dosage of medication, which decreases the chance of a relapse to opioid
Only a handful of articles for Kratom were available and included only small sample sizes. There were many Buprenorphine articles to choose from, because Buprenorphine is approved by the FDA. Also, the articles had large sample sizes which allowed the data to be generalized to all opioid dependent patients. Most research attached to Kratom is of self medicating Kratom users, most of which mix other drugs with Kratom and become ill. In some of the cases the benefits of Kratom include reduced opioid withdrawal symptoms and mild withdrawal symptoms when Kratom is ceased. Extended treatment of Buprenorphine, with counseling or a support system, is associated with better success. This could be due to the fact that patients are more compliant to take the prescribed dosage of medication, which decreases the chance of a relapse to opioid